Effect of Autologous Platelet-Rich Plasma Drops in the Treatment of Ocular Surface Disease.

Jennifer B NadelmannVatinee Y BunyaGui-Shuang YingPeiying HuaMina Massaro-Giordano

Published in: Clinical ophthalmology (Auckland, N.Z.) (2022)

Treatment with PRP drops was associated with a significant improvement in symptoms in patients with ocular surface disease. Future larger prospective studies are needed to further evaluate the efficacy of PRP drops for treating ocular surface disease.

Keyphrases

platelet rich plasma
bone marrow
combination therapy
mesenchymal stem cells
replacement therapy